LCG
APLS

Lisanti Capital Growth’s Apellis Pharmaceuticals APLS Stock Holding History

Lisanti Capital Growth’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,505
Closed -$361K – 113
2024
Q3 		$361K Sell
12,505
-12,380
-50% -$458K 0.09% 116
2024
Q2 		$955K Sell
24,885
-64,325
-72% -$2.91M 0.23% 103
2024
Q1 		$5.24M Buy
89,210
+42,905
+93% +$2.73M 1.28% 25
2023
Q4 		$2.77M Sell
46,305
-64,695
-58% -$3.28M 0.65% 68
2023
Q3 		$4.22M Buy
111,000
+65,505
+144% +$2.88M 0.67% 63
2023
Q2 		$4.14M Sell
45,495
-40,015
-47% -$3.45M 0.57% 79
2023
Q1 		$5.64M Buy
85,510
+29,815
+54% +$1.72M 0.79% 56
2022
Q4 		$2.88M Sell
55,695
-141,595
-72% -$7.51M 0.39% 93
2022
Q3 		$13.5M Buy
197,290
+67,782
+52% +$4.01M 1.8% 12
2022
Q2 		$5.86M Buy
129,508
+79,468
+159% +$3.62M 0.8% 55
2022
Q1 		$2.54M Sell
50,040
-53,385
-52% -$2.36M 0.29% 107
2021
Q4 		$4.89M Buy
+103,425
New +$4.07M 0.71% 65
2021
Q3 		– Sell
-119,445
Closed -$7.55M – 133
2021
Q2 		$7.55M Buy
+119,445
New +$6.16M 0.93% 40
2021
Q1 		– Sell
-134,945
Closed -$7.72M – 128
2020
Q4 		$7.72M Buy
+134,945
New +$5.71M 1.07% 38
2020
Q2 		– Sell
-28,350
Closed -$759K – 119
2020
Q1 		$759K Buy
+28,350
New +$1.01M 0.25% 96

Other funds holding APLS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Lisanti Capital Growth's APLS Position: Q4 2024 in Review

Lisanti Capital Growth sold out of Apellis Pharmaceuticals (APLS) in Q4 2024, closing a stake of 12,505 shares — an estimated $361K sold.

Lisanti Capital Growth first reported a position in APLS in Q1 2020 and held it in 15 quarters. The position peaked at $13.5M in Q3 2022. 260 funds tracked by Wall St. Rank hold APLS as of Q4 2024.

  • Lisanti Capital Growth reported no remaining Apellis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Lisanti Capital Growth sold 12,505 Apellis Pharmaceuticals shares in Q4 2024, an estimated $361K.
  • Lisanti Capital Growth first reported a position in Apellis Pharmaceuticals in Q1 2020 and held it in 15 quarters.
  • Lisanti Capital Growth's Apellis Pharmaceuticals position peaked at $13.5M in Q3 2022.
  • 260 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q4 2024.

Based on Lisanti Capital Growth's 13F filing for Q4 2024, filed 7 Feb 2025.